contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


dagens-aktienyheder-1103-2026-gubra-og-rtx

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Equity Research Assistant

Victor Skriver

Gubra is a pharmaceutical company. The company's operations are focused on the early stages of drug development. They primarily conduct research and development in the area of metabolic and fibrotic diseases. The company's product portfolio includes several brands and drugs, and the operations are conducted on a global level, with the largest presence in North America and the Nordic region. The headquarters are located in Hørsholm, Denmark.

Gubra

RTX is an IT company that focuses on the development of wireless communication for industry and healthcare. The services include a wide range of cloud-based services, IP solutions, system integration, and radio systems. In addition, mechanical design is offered adapted for 3D and PABX-integrated solutions. Customers are found among small and medium-sized companies. RTX was founded in 1993 and is headquartered in Nørresundby, Denmark.

Dagens aktienyheder 11/03-2026: Gubra og RTX

Efter et par dage med vilde kursudsving oven p&#xe5;, at partneren AbbVie offentliggjorde fase 1-data p&#xe5; ABBV-295, havde vi i g&#xe5;r forn&#xf8;jelsen af et event, hvor data og studiedesign blev pr&#xe6;senteret. Q&amp;A-sessionen gav indsigt i, hvordan resultaterne kan benchmarkes mod Eli Lillys elorantide, som aktuelt betragtes som et f&#xf8;rende referencepunkt i feltet, samt yderligere perspektiver p&#xe5; dosisafh&#xe6;ngighed og andre potentielt differentierende faktorer. Se eventet her: <a href="https://www.inderes.dk/videos/gubra-presentation-of-phase-1-topline-results-on-abbv-295-long-acting-amylin-analog">https://www.inderes.dk/videos/gubra-presentation-of-phase-1-topline-results-on-abbv-295-long-acting-amylin-analog</a>. Du kan ogs&#xe5; l&#xe6;se yderligere om dette i vores kommentar p&#xe5; data: <a href="https://www.inderes.dk/analyst-comments/gubra-abbv-295-data-doesnt-seem-that-far-from-eli-lillys-phase-1-data-on-eloralintide">https://www.inderes.dk/analyst-comments/gubra-abbv-295-data-doesnt-seem-that-far-from-eli-lillys-phase-1-data-on-eloralintide</a>
RTX meddelte i g&#xe5;r at selskabet har gennemf&#xf8;rt en kapitalneds&#xe6;ttelse, der afspejler annulleringen af egne aktier erhvervet under selskabets aktietilbagek&#xf8;bsprogram. S&#xe5;ledes reduceres antallet af udest&#xe5;ende aktier med 170.000 stk. til nu 8.297.838, svarende til en reduktion lige omkring 2%.
Disclaimer: HC Andersen Capital modtager betaling fra de n&#xe6;vnte selskaber for en Digital IR abonnementsaftale. /Victor Skriver d. 11/03-2026 kl. 08:52.

HC Andersen Capital

Faron Pharmaceuticals

Herantis Pharma

Mendus

Probabilities of success in drug development

Financial Key Ratios: EV/EBIT, EV/EBITA, EV/EBITDA, and EV/Sales

Nordea Bank

Nordea shareholder? It’s easier than ever to attend the AGM with a new digital set-up

Return on capital (ROE, ROI, ROIC, RONIC)

Balance sheet, debt leverage and risks

Stay up to date